Où achat cialis sans ordonnance et acheter viagra en France.


Serious bacterial infections in newborn infants in developingcountriesDavid Osrin, Stefania Vergnano and Anthony Costello The overwhelming majority of the world’s annual 4 million The Millennium Development Goals include a reduc- neonatal deaths occur in developing countries. This review tion in child mortality by two-thirds between 1990 and therefore briefly addresses the burden, aetiology, prevention 2015 [1]. The number of children under 5 years of age and management of serious neonatal bacterial infections in low- that die each year is 10.8 million, making up 32% of global deaths [2]. Neonatal deaths account for about half of these [3,4.] and two-thirds of infant deaths [5], Bacterial infection is the biggest cause of neonatal admissions proportions which rise as post-neonatal mortality falls to hospitals, and probably the biggest cause of morbidity in the [4.,6]. Of the estimated 3.9 million annual neonatal community, but its burden is unclear. The commonest serious deaths [3,4.], 98% occur in developing countries [7].
infections involve bacteraemia, meningitis and respiratoryinfection, and case fatality rates may be as high as 45%. Key This overview addresses the burden, aetiology, preven- pathogens are Escherichia coli, Klebsiella species, tion and management of serious neonatal bacterial Staphylococcus aureus and Streptococcus pyogenes. The infections in low-income countries. Malaria, tuberculosis, incidence of neonatal infections with group B streptococcus is HIV/AIDS and other viral or sexually transmitted highly variable, as is the spectrum of antimicrobial resistance.
infections are not its focus. The rural, home-born neonate remains relatively invisible to either research Current areas of research include the rectification of or health services and – despite the figures above – the micronutrient deficiencies, neonatal skin care, appropriate burden of neonatal mortality in low-income countries is breastfeeding recommendations, cleansing of the birth canal, barely quantified [8.]. Although a range of strategies for and simplified methods of diagnosis of infection. Operational prevention and management have been proposed, the activities include the control of neonatal tetanus, the diagnosis gaps between the conceptual bases of these strategies and treatment of sexually transmitted infections, integrated strategies for improving pregnancy, childbirth and neonatalsurvival, community-based management of acute respiratory infections, and community-based management of neonatal Most births in developing countries take place at home,as do most neonatal deaths. The major causes of death are likely to be infections, preterm birth and birth developing countries, essential newborn child care, neonatal asphyxia [7]. The incidence of neonatal bacterial illness is unclear [9,10]. In major reviews by Stoll [11,12],hospital data suggested that infection was a cause of 4– Curr Opin Infect Dis 17:217–224. # 2004 Lippincott Williams & Wilkins.
56% of neonatal deaths, and community data a figure of8–84% [11]. These figures yielded an estimate of 1.5– International Perinatal Care Unit, Centre for International Child Health, Institute of 2 million infection-related neonatal deaths per annum Child Health, University College London, London, UK [11,12]. World Health Organization (WHO) estimates Correspondence to Dr David Osrin, International Perinatal Care Unit, Institute of Child suggest that sepsis, pneumonia, tetanus and diarrhoea Health, 30 Guilford Street, London WC1N 1EH, UK Tel: +44(0) 207 905 2261; fax: +44(0) 207 404 2062; e-mail: d.osrin@ich.ucl.ac.uk Current Opinion in Infectious Diseases 2004, 17:217–224 The variability of these estimates underlines five issues.
(1) The invisibility of the neonatal period makes pick-up rates variable. (2) There are difficulties in diagnosingneonatal infection and in disaggregating it from other potential causes of death, and the clinical tools available for diagnosis in poorer settings are limited. (3) The siteof research is important: hospital-based studies haveoften been conducted in tertiary units, may includehigher proportions of preterm infants, generally recruiturban participants of higher socioeconomic status, often include more male infants, and tend to miss early 73 per 1000 live births, and the prevalence of low birth neonatal illness and mortality. (4) All research in low- weight was high (42%); 763 neonates were observed and income countries faces the problems of workload, 17% developed clinical features suggestive of sepsis.
opportunity and consumable costs, and variations in Although it is possible that the clinical ascription of the quality of laboratory procedures. (5) These issues sepsis was over-inclusive, the case fatality rate in infants aside, there is likely to be a wide range of incidences and in this category was 18.5%, even when the subjects were case fatality rates across geographic, socioeconomic and treated with oral antibiotics. The investigators noted that no neonate was seen at a primary health centre, and thatif all who merited a visit had been seen, the primary health-care system would have been overloaded.
bacterial infectionAttempts to measure morbidity are confused by the selective nature of studies, particularly the recruitment Reviewing 18 hospital-based studies in 1989, a WHO of sick infants at health facilities [14]. In a hospital-based expert group concluded that the aetiology of commu- study from Karachi, Pakistan, infection was the biggest nity-acquired pneumonia – and, by implication, sepsis – cause of hospitalization of newborn infants [13], and at a in young infants in developing countries was unknown district hospital in Kenya, where 95% of admissions were [20]. Subsequently, the WHO Young Infants Study outborn, serious infections were the most common cause Group attempted to describe pathogenic organisms in of admission for infants under 2 months of age [15.]. In young infants as close to community settings as possible.
their review of sepsis neonatorum of 1981, Siegel and Four country sites were involved: a hospital in Addis McCracken [16] suggested that the primary site of Ababa, Ethiopia [21], a research institute in Alabang, the invasion was most often the bloodstream, with spread to Philippines [22], a base hospital in the eastern highlands the meninges in 25–30% of cases. Other clinical entities of Papua New Guinea [23], and two sites in the Gambia included acute respiratory infection, diarrhoea, and (a first-level facility and a referral hospital) [24]. Infants omphalitis, itself associated with neonatal tetanus. In were enrolled on presentation at under 3 months of age, clinical series, congenital and neonatal pneumonias are using a formalized sequence of assessment and investi- often grouped with sepsis and meningitis because of the gations; 8418 infants were triaged, 4552 enrolled, and overlap in symptom constellations. The Kenyan study [15.] looked at 432 early neonatal and 260 late neonataladmissions. Sepsis accounted for 30% of early neonatal In the neonatal period, the commonest blood-culture admissions, tetanus for 6%, and meningitis for 1%. In the isolates were Staphylococcus aureus (23%), Streptococcus late neonatal period, sepsis accounted for 60% of pyogenes (20%), and Escherichia coli (18%). Cerebrospinal admissions, tetanus for 7%, and meningitis for 4% [15.]. Stoll’s reviews [11,12] put the global incidence meningitis was predominantly caused by Gram-nega- of neonatal sepsis at 5–6 per 1000 live births and that of tive micro-organisms, and late neonatal meningitis was meningitis at 0.7–1 (2.4–16 in South and South-East caused by roughly equal numbers of Gram-negative Asia, 6–21 in sub-Saharan Africa, and 1.8–12 in the micro-organisms and Streptococcus pneumoniae, particularly Middle East and North Africa) [11]. Estimates of case of serotype 2. This trend was supported by the tendency fatality rates for neonatal infections range from 13% to for post-neonatal meningitis to be dominated by Strep.
45% [11,12]. There is some evidence that infants pneumoniae, which accounted for 43% of proven bacterial delivered to poorer families at home have higher case meningitis. There were differences between sites: Staph.
fatality rates, but this may also reflect later consultation aureus was commoner in the Gambia (possibly the result of a high prevalence of scabies), E. coli in Ethiopia [21],Salmonella in the Philippines [22], and Strep. pyogenes in Community-based studies are rare and vary in their Papua New Guinea [23]. At the same site, nasophar- classification of neonatal sepsis. In a prospective study of yngeal aspirates were positive for Chlamydia trachomatis 329 births in rural Guatemala [18], infection was the in 33% of severe pneumonias – an issue that requires largest cause of morbidity and mortality. Mortality from further study [27]. Despite the investigators’ efforts, the infectious illness was more common in the early neonatal sampling frame was hospital-based, so the recruitment period and in preterm and low-birth-weight infants, pool would have omitted infants who did not present to although the majority of illnesses occurred in term a facility. This is true of almost all previous and infants of normal birth weight. In Maharashtra, India, subsequent studies, of which there have been many, Bang and colleagues [19] employed village-based female and of which a brief summary follows.
health workers to describe the burden of morbidities byusing a clinical algorithm. At the time, 95% of births took There appears to be regional variation in the split place at home, the infant mortality ratio in the area was between Gram-positive and Gram-negative pathogens.
Serious infections in developing countries Osrin et al.
The split has been about even in studies from sub- Saharan Africa, but Gram-negative micro-organisms have Although it is not clear how much institutional spectra been more common in Asian studies [11,25,26]. In all of resistance are applicable to the community, institu- series, the most common Gram-negative pathogens have tional infection control presents its own problems [53].
been Klebsiella species and E. coli [15.,17,28–37]. It is Degrees of resistance vary: some centres report low levels quite likely that E. coli, a more common isolate in outborn [28,54], while others report rapid increases in multidrug- neonates and in vaginal swabs from women in rural areas resistant neonatal infections [30,31,34,36,37,55]. In unu- [38], reflects community patterns of colonization and sual but worrying situations, first-line therapy comprises infection. Klebsiella species have often been isolated in vancomycin and amikacin or a carbapenem [34].
hospital series and are often implicated in nurseryoutbreaks [39,40]. Other important pathogens have been Reducing the burden of neonatal bacterial found to be Pseudomonas and Enterobacter species. The most common Gram-positive isolate has been found to be The importance of neonatal survival in developing Staph. aureus [17,28,31,33,34,36,37,41,42]. Studies from countries has been addressed over the last decade by a the Caribbean yield similar isolates, but show the effect of number of reviews, working groups and alliances nosocomial outbreaks of Pseudomonas infection [43] and a [3,8.,11,56–62,63.,64]. The following list summarizes rising incidence of neonatal sepsis associated with group recommendations for the reduction of neonatal morbid- ity and morbidity from bacterial infection. Theserecommendations It is difficult to generalize about the importance of group sources [3,8.,11,56–62,63.,64], as well as from the B streptococcal infection. Until recently, the limited role WHO initiatives for Essential Newborn Care [65], the of group B streptococcus in neonatal sepsis in developing Mother–Baby Package [66] and the Integrated Manage- countries was a point of discussion [11,25,26]. It ment of Pregnancy and Childbirth [67].
accounted for less than 1% of infections in Asian studiesand about 8% in African studies, which is surprising in view of the possibility that maternal colonization levels appeared similar to those in high-income countries [11].
Gender equity and education for women.
In a 10-year retrospective series from a tertiary care perinatal centre in Vellore, India, the incidence of Political commitment to improving neonatal survival.
symptomatic early neonatal group B streptococcal bacter- Improvements in general health and health care aemia was as low as 0.17 per 1000 live births [46]. The Improved access to, and quality of, health services.
problem may be increasing, however [15.,42]. It is not clear whether group B streptococcal sepsis runs, to some Integration of health service and community activities, extent, in parallel with the epidemiological transition, or with the emphasis on community-based aspects of whether there is a connection with clustering in hospital births [47–49]. Regular monitoring of pathogens in institutional centres is necessary in order to pick up Improvements in mother and child health care evolving patterns of infection. Identification of rising National strategy to reduce neonatal mortality.
rates of group B streptococcal infection allows screening Surveillance of vital events and neonatal outcomes.
and response protocols to be put in place, in the absence Reduced prevalence of low birth weight.
of which case fatality rates can be as high as 60% [50].
Integration of neonatal survival into existing safe- motherhood and child-survival programmes.
Availability, quality and uptake of antenatal care.
Ampicillin and gentamicin are currently recommended as first-line antimicrobials [26,42,51], ampicillin replacing the previous recommendation of penicillin [52]. An Knowledge of maternal and neonatal danger signs in antistaphylococcal agent such as cloxacillin may be added when scabies or pustular skin lesions are present, and a Recognition, management and referral of maternal and third-generation cephalosporin should be considered for suspected meningitis. The emergence of resistant patho- gens is a problem for both institutions and communities.
Rahman and colleagues [36] ably summarize the situation Focused antenatal care, i.e. a limited number of visits in many areas: lack of control of antibiotic use, little with specific effective activities.
legislation on prescription, over-the-counter sale of Antenatal micronutrient supplementation (the evi- antibiotics, poor sanitary conditions, a lack of basic dence for effects on neonatal infection are currently facilities that would help hand-washing, and a lack of Immunization: tetanus toxoid administration before 1% to 8% [73] among pregnant women attending for and during antenatal care. Pneumococcal and antenatal care, but estimates are more reliable in settings Haemophilus influenzae type B vaccines are under with higher antenatal care uptake. In a survey of 22 countries in sub-Saharan Africa, where antenatal care Facility-based and community-based training of birth attendance is around 72%, only 38% of attendees were screened and treated for syphilis. This leaves over Diagnosis and treatment of sexually transmitted and 1 million women untreated despite the existence of cost- Planning for clean, safe delivery (‘birth preparedness’).
Action to address infective complications: partography, What models do we have for achieving some of the far- limited vaginal examinations, antibiotic prophylaxis reaching and ambitious changes recommended in the above list? The success of the WHO strategy of Clean delivery: skilled attendance, hand-washing, use identification and case management of acute respiratory of clean delivery kit, clean cord cutting and infection in the community is now clear. However, field activities exclude infants below the age of 2 months who Neonatal care: essential training on newborn infant should be referred for management in hospital [75,76]. A care for health workers, support for breast-feeding, meta-analysis of nine community-based trials of case ‘rooming in’ at facilities, identification of preterm management of pneumonia in preschool children in and low-birth-weight infants, kangaroo mother care developing countries (all but one in Asia, the other in for low-birth-weight infants, prophylaxis against Africa) yielded a summary estimate for reduction in all- ophthalmia neonatorum, early immunization, post- cause neonatal mortality of 27% (95% confidence partum maternal care linked with newborn care, interval, 18–35%). The reduction in neonatal pneumonia mortality was 42% (22–57%). Of particular interest was Home-based diagnosis and treatment of neonatal the finding that case management was successful in the neonatal period, and that it allowed for a range ofactivities that did not necessarily require the use of It is important to ensure that recommendations are evidence-based. However, the history of the primaryhealth-care movement alerts us to an understandable The Integrated Management of Childhood Illness tendency to dwell on biomedical and technical aspects of strategy of the WHO covers three areas: improving the the agenda at the expense of the organizational, social skills of health personnel in the prevention and and political changes that it demands [68]. There is a treatment of childhood illness; improving health systems wide gap between the requirements and our knowledge to deliver quality care; and improving family and of how to meet those needs at operational level. This is community practices in relation to child health [78].
particularly true of community-based activities.
The activities of the Integrated Management of Child-hood Illness have so far excluded the infant under 2 An exception is the control of neonatal tetanus: despite months of age, but neonatal guidelines are currently setbacks that resulted in shifting of the target date to being drawn up and adapted. Some of the studies 2005 [69], there has been steady progress towards the mentioned in this review have been explicitly oriented elimination of the infection [70]. Incidence fell by about towards this [15.,25,79.], and the ideal would be to 75% over the decade to 2000, at which point about dovetail the Integrated Management of Childhood 200 000 cases were reported [71]. Activities are currently Illness work with the Integrated Management of focused on 57 countries. The key strategies are Pregnancy and Childbirth practice guide [67]. The promotion of clean deliveries (which has implications emphasis of the activities of the Integrated Management for other bacterial infections), surveillance and immuni- of Childhood Illness so far has been on the tools and zation. Routine tetanus toxoid immunization is augmen- training of health personnel [80]. This may lead to ted by supplemental activities, a high-risk approach improvements in quality that themselves encourage involving immunization of all women of child-bearing greater uptake of services, but there is a danger that age (in specific areas) with three doses of tetanus toxoid.
health-system and community requirements will achieveless attention [81–83].
Diagnosis and treatment of sexually transmitted infec-tions is becoming a priority, especially with respect to A trial of a community-based model designed to improve the HIV pandemic. Syphilis infection is particularly neonatal outcomes in rural Maharashtra, India, has had a relevant to neonatal health, being responsible for strong influence on current opinion [84]. The non- stillbirths, low birth weight, preterm delivery and randomized trial involved 39 intervention and 47 control congenital infection [72]. Its prevalence ranges from villages. In the first year of activities, female village Serious infections in developing countries Osrin et al.
health workers collected data and managed minor low-birth-weight prevalence and an increase in labora- illnesses and pneumonia in neonates. In the second tory measures of maternal immunocompetence [93], but year, they undertook case management of neonatal the effects on bacterial infection are unclear.
illnesses, including the identification and treatment ofpresumptive sepsis with intramuscular gentamicin and oral cotrimoxazole. In the third year, health education for A recent review explores the possibility that topical mothers and grandmothers was added to the package.
application of natural vegetable oils might boost the Sepsis was suggested by a combination of any two of skin’s barrier properties. If this were the case, traditional eight possible symptoms or signs, and hospital treatment oil massage might be a means of reducing neonatal was advised, home-based management being a second infection, especially in preterm and small infants [94].
option. The study described a reduction in neonatal Sunflower seed oil accelerated the recovery of mouse sepsis mortality from 27.5 to 6.6 per 1000 live births.
epidermal barrier function and electron micrographic There are some difficulties in interpretation and extra- ultrastructure, whereas mustard oil – commonly applied polation: (1) the non-random nature of the sample and its in developing countries – was prone to a lack of purity, reliance on two clusters; (2) the inclusiveness of the and caused deterioration in barrier function.
clinical diagnostic criteria; (3) the stepwise introductionof a number of interventions; and (4) the reliance on a cadre parallel to government staff. Nevertheless, it A pooled analysis of data from three developing country seems that locally trained workers can undertake case studies (Brazil, Pakistan, and the Philippines) looked at management of neonatal sepsis and administer paren- the protective effect of breast-feeding against mortality teral antibiotics safely, and efforts are underway to from infectious disease. The pooled odds ratio for systematize once-daily regimens and safe injection infectious mortality associated with not breast-feeding technology. The possibility of home-based care for in the first month of life was 5.8 (95% confidence neonatal illness has been raised, and the next steps are interval, 3.4–9.8). Unfortunately, deaths in the first week modification of the model, replication and expansion.
were excluded from the analysis [95]. Breast-feedingrecommendations in countries with high HIV prevalence are a subject of debate and current research. An example A number of other issues relevant to neonatal bacterial is the study from Kenya in which HIV-infected mothers infection have seen research activity over the last few were randomized to either exclusively breast-feed or formula feed. On one hand, the breast-feeding groupshowed a higher rate of mother-to-child HIV transmis- sion; on the other, by the time the infants were 2 years A link between micronutrient deficiencies – either single old the groups had comparable all-cause mortality or multiple – and neonatal infection is plausible [85].
Although a number of studies are under way, we do notpresently have evidence that improvements in micro- nutrient status, with the exception of vitamin A, would A study from Malawi [98] showed a significant reduction lead to reductions in infection-specific morbidity or in early neonatal infections, admissions and mortality mortality [86]. Vitamin A supplementation for children when chlorhexidine was used to clean the birth canal at aged over 6 months could reduce childhood mortality by delivery. This simple, affordable intervention warrants about one-quarter [87], at least part of this being mediated by a reduction in infectious morbidity.
However, supplementation for infants in the later Prediction of neonatal bacterial infection neonatal period has not been shown to reduce morbidity A score-based or algorithmic system for identifying [88] or mortality [89]. It is possible that earlier presumptive neonatal bacterial infection would be useful intervention would be beneficial: an Indonesian trial given the difficulty of diagnosis [99–101]. In a hospital- [90] in which most infants received supplements on the based sample from Delhi, India, a respiratory rate of over first day of life showed a 64% reduction in infant 60 breaths/min was 88.3% sensitive and 6.3% specific for mortality, and an Indian trial [91.] showed a promising neonatal pneumonia; chest retractions were 93.2% mortality reduction in the first 3 months of life when sensitive and 36.1% specific [35]. The WHO Young vitamin A supplements were given in the first 48 h.
Infants Study used regression and receiver–operator Unfortunately, we do not have evidence that supple- modelling to generate a list of 14 historical factors and mentation for mothers during pregnancy reduces neo- signs that were independently predictive of severe disease [79.]. The presence of any factor had a controlled trial of multivitamin supplements for pregnant sensitivity for severe disease of 87% and a specificity HIV-infected women in Tanzania showed a reduction in of 54%. A model involving nine factors had slightly lower sensitivity but greater specificity, but further reductions 13 Bhutta Z. Neonatal bacterial infections in developing countries: strategies for prevention. Semin Neonatol 1999; 4:159–171.
in complexity were associated with losses of sensitivity.
14 Leach A, McArdle T, Banya W, et al. Neonatal mortality in a rural area of The This is a large number of considerations on which to Gambia. Ann Trop Paediatr 1999; 19:33–43.
base a simple model for use by rural health cadres. It 15 English M, Ngama M, Musumba C, et al. Causes and outcome of young remains to be tested in settings where more first-week infant admissions to a Kenyan district hospital. Arch Dis Child 2003; 88:438–443.
infants are seen and where infants are unselected so that This prospective observational study carried out in a Kenyan district hospital the model has to deal with populations in which the underlines the importance of the neonatal period to the burden of mortality, as wellas that of infection. The importance of Strep. pneumoniae in sepsis in young likelihood of serious illness is lower.
infants, noted in the WHO Young Infants Study, is supported.
16 Siegel J, McCracken G. Sepsis neonatorum. N Engl J Med 1981; 304:642– Despite the scarcity of research information on bacterial 17 Bhutta Z, Yusuf K. Neonatal sepsis in Karachi: factors determining outcome infections in newborn infants in low-income countries, and mortality. J Trop Pediatr 1997; 43:65–70.
intervention to reduce their burden is a priority.
18 Bartlett A, Paz de Bocaletti M, Bocaletti M. Neonatal and early postneonatal morbidity and mortality in a rural Guatemalan community: the importance of Research should focus on scalable activities at commu- infectious diseases and their management. Pediatr Infect Dis J 1991; nity level, linked with health-system strengthening. This would also provide opportunities for surveillance in- 19 Bang A, Bang R, Baitule S, et al. Burden of morbidities and the unmet need for health care in rural neonates – a prospective observational study in itiatives and the testing of technical package compo- Gadchiroli, India. Ind Pediatr 2001; 38:952–965.
20 World Health Organization. Clinical signs and etiological agents of pneumonia, sepsis and meningitis in young infants. Report of meeting,Geneva 21–24 November 1989. Geneva: World Health Organizationprogramme for control of acute respiratory infections, WHO/ARI/90.14; Papers of particular interest, published within the annual period of review, have 21 Muhe L, Tilahun M, Lulseged S, et al. Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J 1999; 18 (Suppl):S56–S61.
22 Gatchalian S, Quiambao B, Morelos A, et al. Bacterial and viral etiology of serious infections in very young Filipino infants. Pediatr Infect Dis J 1999; 18 United Nations General Assembly, 56th session. Road map towards the implementation of the United Nations millennium declaration: report of theSecretary-General (UN document no. A/56/326). New York: United Nations; 23 Lehmann D, Michael A, Omena M, et al. Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua NewGuinea. Pediatr Infect Dis J 1999; 18 (Suppl):S42–S49.
Murray C, Lopez A. Mortality by cause for eight regions of the world: GlobalBurden of Disease study. Lancet 1997; 349:1269–1276.
24 Mulholland E, Ogunlesi O, Adegbola R, et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J 1999; 18 (Suppl):S35–S41.
Saving Newborn Lives. State of the world’s newborns. Washington, DC: 25 World Health Organization Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a Black R, Morris S, Bryce J. Where and why are 10 million children dying multicenter study. Pediatr Infect Dis J 1999; 18 (Suppl):S17–S22.
every year? Lancet 2003; 361:2226–2234.
26 World Health Organization Young Infants Study Group. Conclusions from the This is the first of a series of papers on child survival. It is a secondary analysis of WHO multicenter study of serious infections in young infants. Pediatr Infect existing information that attempts to locate and look at risk factors for child mortality. The paper locates mortality figures globally and divides countries intotypology groups. It points out the importance of neonatal mortality and infectious 27 Lehmann D, Sanders R, Marjen B, et al. High rates of Chlamydia trachomatis infections in young Papua New Guinean infants. Pediatr Infect Dis J 1999; 18(Suppl):S62–S69.
Rutstein S. Factors associated with trends in infant and child mortality indeveloping countries during the 1990s. Bull World Health Organ 2000; 28 Anwer S, Mustafa S, Pariyani S, et al. Neonatal sepsis: an etiological study. J Claeson M, Bos E, Mawji T, Pathmanathan I. Reducing child mortality in India 29 Joshi S, Ghole V, Niphadkar K. Neonatal gram-negative bacteremia. Indian J in the new millennium. Bull WHO 2000; 78:1192–1199.
World Health Organization. Perinatal mortality: a listing of available 30 Musoke R, Revathi G. Emergence of multidrug-resistant Gram-negative information. Geneva: World Health Organization, FRH/MSM/96.7; 1996.
organisms in a neonatal unit and the therapeutic implications. J Trop Pediatr2000; 46:86–91.
Committee on Improving Birth Outcomes. Board on Global Health. Improving birth outcomes. Meeting the challenge in the developing world. Washington: 31 Karthikeyan G, Premkumar K. Neonatal sepsis: Staphylococcus aureus as the predominant pathogen. Indian J Pediatr 2001; 68:715–717.
This is a report based on discussions and recommendations by an expert panel.
32 Ahmed A, Chowdhury M, Hoque M, Darmstadt G. Clinical and bacter- The report considers both mothers and newborn infants, and summarizes the iological profile of neonatal septicemia in a tertiary level pediatric hospital in evidence for interventions to improve outcomes. The uncertainty as to what Bangladesh. Indian Pediatr 2002; 39:1034–1038.
specific activities would be beneficial and cost-effective is reflected in a partial lackof consensus in the recommendations.
33 Kumhar G, Ramachandran V, Gupta P. Bacteriological analysis of blood culture isolates from neonates in a tertiary care hospital in India. J Health Dawodu A, Alausa O. Neonatal septicaemia in the tropics. Afr J Med Sci 34 Mahmood A, Karamat K, Butt T. Neonatal sepsis: high antibiotic resistance of 10 Robillard P, Nabeth P, Hulsey T, et al. Neonatal bacterial septicemia in a the bacterial pathogens in a neonatal intensive care unit in Karachi. J Pak Med tropical area. Four-year experience in Guadeloupe (French West Indies).
35 Mathur N, Garg K, Kumar S. Respiratory distress in neonates with special 11 Stoll B. The global impact of neonatal infection. Clin Perinatol 1997; 24:1–21.
reference to pneumonia. Indian Pediatr 2002; 39:529–553.
12 Stoll B. Neonatal infections: a global perspective. In: Remington J, Klein J, 36 Rahman S, Hameed A, Roghani M, Ullah Z. Multidrug resistant neonatal editors. Infectious diseases of the fetus and newborn infant. Philadelphia: WB sepsis in Peshawar, Pakistan. Arch Dis Child Fetal Neonatal Ed 2002; Serious infections in developing countries Osrin et al.
37 Waheed M, Laeeq A, Maqbool S. The etiology of neonatal sepsis and 63 Darmstadt G, Lawn J, Costello A. Advancing the state of the world’s patterns of antibiotic resistance. J Coll Physicians Surg Pak 2003; 13:449– newborns. Bull World Health Organ 2003; 81:224–225.
This advocacy paper highlights the importance of neonatal mortality and infections,our lack of knowledge about newborn infants in developing countries, and the 38 Bang A, Bang R, Morankar V, et al. Pneumonia in neonates: can it be need for well-designed trials of potential interventions.
managed in the community? Arch Dis Child 1993; 68:550–556.
64 Jones G, Steketee R, Black R, et al. Child survival II. How many child deaths 39 Nanthoo K, Mason P, Gwanzura L, et al. Severe Klebsiella infection as a can we prevent this year? Lancet 2003; 362:65–71.
cause of mortality in neonates in Harare, Zimbabwe: evidence from post-mortem blood cultures. Pediatr Inf Dis J 1993; 12:840–844.
65 World Health Organization. Essential newborn care. Report of a technical working group (Trieste, 25–29 April 1994). Geneva: World Health 40 Boo N, Chor C. Six year trend of neonatal septicaemia in a large Malaysian Organization, Division of Reproductive Health (Technical Support); 1996.
maternity hospital. J Paediatr Child Health 1994; 30:23–27.
41 Ayoola O, Adeyemo A, Osinusi K. Aetiological agents, clinical features and outcome of septicaemia in infants in Ibadan. West Afr J Med 2003; 22:30– 66 World Health Organization. Mother–baby package: implementing safe motherhood in countries. Geneva: Maternal Health and Safe MotherhoodProgramme, World Health Organisation, FHE/MSM/94.11; 1994.
42 Laving A, Musoke R, Wasunna A, Revathi G. Neonatal bacterial meningitis at the newborn unit of Kenyatta National Hospital. Ann Trop Paediatr 2003; 67 World Health Organization. Integrated management of pregnancy and childbirth. Essential care practice guide for pregnancy, childbirth andnewborn care. Geneva: World Health Organization, Department of Repro- 43 Orrett F, Shurland S. Neonatal sepsis and mortality in a regional hospital in Trinidad: aetiology and risk factors. Ann Trop Paediatr 2001; 21:20–25.
68 Tarimo E, Webster E. Primary health care concepts and challenges in a 44 Ali Z. Neonatal Group B streptococcal infection at the Mount Hope Women’s changing world. Current concerns ARA Paper number 7. Geneva: World Hospital, Trinidad. Child Care Health Dev 2004; 30:1–3.
Health Organization. WHO/ARA/CC/97.1; 1997.
45 Orrett F. Colonization with Group B Streptococci in pregnancy and outcome 69 World Health Organization/United Nations Children’s Fund/United Nations of infected neonates in Trinidad. Pediatr Int 2003; 45:319–323.
Fund for Population Activities. Maternal and neonatal tetanus elimination by 46 Kuruvilla K, Thomas N, Jesusdasan M, Jana A. Neonatal Group B 2005. Strategies for achieving and maintaining elimination. Geneva: World Streptococcal bacteraemia in India: ten years’ experience. Acta Paediatr Health Organization/United Nations Children’s Fund/United Nations Fund for 47 Miura E, Martin M. Group B Streptococcal neonatal infections in Rio Grande 70 Vandelaer J, Birmingham M, Gasse F, et al. Tetanus in developing countries: do Sul, Brazil. Rev Inst Med Trop S Paolo 2001; 43:243–246.
an update on the maternal and neonatal tetanus elimination initiative. Vaccine2003; 21:3442–3445.
48 El-Said M, Bessisso M, Janahi M, et al. Epidemiology of neonatal meningitis in Qatar. Saudi Med J 2002; 23:789–792.
71 World Health Organization/United Nations Children’s Fund/World Bank.
State of the world’s vaccines and immunization. Geneva: World Health 49 Sidky I, Thomas M. Prevalence of Group B streptococcal infection colonisation in pregnant women and their offspring in the Middle East. JObstet Gynaecol 2002; 22:179–180.
72 Duke T, Michael A, Mgone J, et al. Etiology of child mortality in Goroka, Papua New Guinea: a prospective two-year study. Bull World Health Organ 50 Vaciloto E, Richtmann R, de Paula Fiod Costa H, et al. A survey of the incidence of neonatal sepsis by group B Streptococcus during a decade in aBrazilian maternity hospital. Braz J Infect Dis 2002; 6:55–62.
73 Gerbase A, Rowley J, Heymann D, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74 (Suppl 51 Daoud A, Abuekteish F, Obeidat A, et al. The changing face of neonatal septicaemia. Ann Trop Paediatr 1995; 15:93–96.
74 Gloyd S, Chai S, Mercer M. Antenatal syphilis in sub-Saharan Africa: missed 52 World Health Organization. Acute respiratory infections in children: case opportunities for mortality reduction. Health Policy Plan 2001; 16:29–34.
management in small hospitals in developing countries. Geneva: Programmefor Control of Acute Respiratory Infections, World Health Organization, 75 World Health Organization. Report of fourth meeting of technical advisory group, 6–10 March 1989. Geneva: World Health Organization Programme of 53 Starling C. Infection control in developing countries. Curr Opin Infect Dis acute respiratory infections, WHO/ARI/89.4; 1989.
76 World Health Organization. Acute respiratory infections in children: case 54 Chaudhury A, Rao T. Bacteraemia in a tertiary care urban hospital in south management in small hospitals in developing countries. Geneva: World India. Indian J Pathol Microbiol 1999; 42:317–320.
Health Organization Programme of acute respiratory infections, WHO/ARI/90.5; 1990.
55 Ali S, Khan T, Zaidi A. Neonatal sepsis in Peshawar [letter]. Arch Dis Child 77 Sazawal S, Black R. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community- 56 National Neonatology Forum of India. National workshop on communication based trials. Lancet Infect Dis 2003; 3:547–556.
strategies for the care of the newborn. Calcutta: National Neonatology Forum This high-quality meta-analysis includes nine studies of community-based manage- ment of acute respiratory infeciton. There were limits to the quality of the trialsincluded, but the meta-analysis is supportive of a role for community-based case 57 Bergsjo P, Villar J. Scientific basis for the content of routine antenatal care. II.
Power to eliminate or alleviate adverse newborn outcomes; some specialconditions and examinations. Acta Obstet Gynecol Scand 1997; 76:15–25.
78 Gove S. Integrated management of childhood illness by outpatient health 58 Darmstadt G, Black R, Santosham M. Research priorities and postpartum workers: technical basis and overview. Bull World Health Organ 1997; 75 care strategies for the prevention and optimal management of neonatal infections in less developed countries. Pediatr Infect Dis J 2000; 19:739– 79 Weber M, Carlin J, Gatchalian S, et al. Predictors of neonatal sepsis in developing countries. Pediatr Infect Dis J 2003; 22:711–716.
59 Carroli G, Rooney C, Villar J. WHO programme to map the best reproductive This represents an attempt to use robust analytical techniques to produce a simple health practices: how effective is antenatal care in preventing maternal diagnostic algorithm for serious neonatal infection. The resulting model is of limited mortality and serious morbidity? Paediatr Perinatal Epidemiol 2001; 15 utility, but the paper opens up the field for further work.
80 Gove S, Tamburlini G, Molyneux E, et al. Development and technical basis of 60 Lawn J, McCarthy B, Ross S. The healthy newborn: a reference manual for simplified guidelines for emergency triage assessment and treatment in program managers. Atlanta: CSC/CARE; 2001.
developing countries. Arch Dis Child 1999; 81:473–477.
61 Fikree F, Azam S, Berendes H. Time to focus child survival programmes on 81 Lambrechts T, Bryce J, Orinda V. Integrated Management of Childhood the newborn: assessment of levels and causes of infant mortality in rural Illness: a summary of first experiences. Bull World Health Organ 1999; Pakistan. Bull World Health Organ 2002; 80:271–276.
62 Villar J, Carroli G, Khan-Neelofur D, et al. Patterns of routine antenatal care 82 Winch P, Leban K, Casazza L, et al. An implementation framework for for low-risk pregnancy (Cochrane Review). In:The Cochrane Library, Issue 1, household and community integrated management of childhood illness.
2004. Chichester, UK: John Wiley & Sons, Ltd.
Health Policy Plan 2002; 17:345–353.
83 Kalter H, Salgado R, Moulton L, et al. Factors constraining adherence to 92 Katz J, West K, Khatry S, et al. Maternal low-dose vitamin A or beta-carotene referral advice for severely ill children managed by the Integrated Manage- supplementation has no effect on fetal loss and early infant mortality: a ment of Childhood Illness approach in Imbabura Province, Ecuador. Acta randomized cluster trial in Nepal. Am J Clin Nutr 2000; 71:1570–1576.
84 Bang A, Bang R, Baitule S, et al. Effect of home-based neonatal care and 93 Fawzi W, Msamanga G, Spiegelman D, et al. Randomised trial of effects of management of sepsis on neonatal mortality: field trial in rural India. Lancet vitamin supplements on pregnancy outcomes and T cell counts in HIV-1- infected women in Tanzania. Lancet 1998; 351:1477–1482.
85 Goldenberg R. The plausibility of micronutrient deficiency in relationship to 94 Darmstadt G, Mao-Qiang M, Chi E, et al. Impact of topical oils on the skin perinatal infection. J Nutr 2003; 133 (Suppl):S1645–S1648.
barrier: possible implications for neonatal health in developing countries. Acta 86 Costello AM, Osrin D. Micronutrient status during pregnancy and outcomes 95 World Health Organization Collaborative Study Team on the Role of 87 Beaton G, Martorell R, Aronson K, et al. Effectiveness of vitamin A Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding supplementation in the control of young child morbidity and mortality in on infant and child mortality due to infectious diseases in less developed developing countries. ACC/SCN State-of-the-art series, Nutrition Policy countries: a pooled analysis. Lancet 2000; 355:451–455.
Discussion Paper No. 13. Toronto: Administrative Committee on Coordina-tion/Subcommittee on Nutrition, United Nations; 1993.
96 Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000; 88 World Health Organization/Child Health Division immunisation-Linked Vitamin A Supplementation Study Group. Randomised trial to assess benefits andsafety of vitamin A supplementation linked to immunisation in early infancy.
Mbori-Ngacha D, Nduati R, John G, et al. Morbidity and mortality in breastfedand formula-fed infants of HIV-1-infected women: a randomized clinical trial.
89 West K, Katz J, Shrestha S, et al. Mortality of infants 56 mo of age supplemented with vitamin A: a randomized, double-masked trial in Nepal.
Am J Clin Nutr 1995; 62:143–148.
98 Taha T, Biggar R, Broadhead R, et al. Effect of cleansing the birth canal with 90 Humphrey J, Agoestina T, Wu L, et al. Impact of neonatal vitamin A antiseptic solution on maternal and newborn morbidity and mortality in supplementation on infant morbidity and mortality. J Pediatr 1996; 128:489– Malawi: clinical trial. BMJ 1997; 315:216–219.
99 Takkar V, Bhakoo O, Narang A. Scoring system for prediction of early 91 Rahmathullah L, Tielsch J, Thulasiraj R, et al. Impact of supplementing neonatal infection. Indian Pediatr 1974; 11:597–600.
newborn infants with vitamin A on early infant mortality: community basedrandomised trial in southern India. Br Med J 2003; 327:254–259.
In this double-blind, randomized, controlled trial, infants received vitamin A or 100 World Health Organization Young Infants Study Group. Clinical prediction of placebo starting within 48 h of birth. The vitamin A recipient group showed a serious bacterial infections in young infants in developing countries. Pediatr mortality reduction of 23% over the first 6 months, most of the effect appearing in Infect Dis J 1999; 18 (10 Suppl):S23–S31.
the first 3 months. The study suggests that early neonatal vitamin A supplementa-tion could reduce infant mortality, but more work is required on efficacy, subgroup 101 Singh S, Dutta S, Narang A. Predictive clinical scores for diagnosis of late onset neonatal septicemia. J Trop Pediatr 2003; 49:235–239.

Source: http://www.mira.org.np/osrincoid2004.pdf


M A T E R I A L S A F E T Y D A T A S H E E T Prescription Treatment® brand ULTRACIDE® Pressurized Flea IGR & Adulticide Formula 1 EMERGENCY PHONE NUMBERS: MEDICAL: 800-225-3320 (Prosar) TRANSPORTATION: 800-424-9300 (Chemtrec) SECTION 1. PRODUCT AND COMPANY IDENTIFICATION SECTION 5. FIRE FIGHTING MEASURES Product Name: Prescription Treatment® brand ULTRACIDE® Pr

Microsoft word - mentor application 08 _2_.doc

Name: __________________________________________________ Street Address: ___________________________________________ City: _____________________________ Zip:___________________ Daytime Phone: _______________ Evening Phone: ___________ Email Address:____________________________________________ Highest Level of Education Completed: Current College students please fill out the following sectio

Copyright © 2010-2014 Pdf Medic Finder